Intelligent Medical Device

Reimagining
Advanced Life Support.

Eleusô is setting a new standard in advanced life support — the first hybrid axial Advanced Life Support pump designed to be compact, practically automated, and deployable beyond the OR/ICU.

FDA Pathway · Active
Flow 5+ L/min · COMPATIBLE with any caNnula and oxygenator
Eleusô assembly cutaway — engineering visualization
Engineering visualization
Step 01 / 03

Compact.
Intelligent.
Ready.

Conventional Advanced Life Support machines are large, complex, and require dedicated ICU teams. Eleusô is fundamentally different — a compact, self-contained pump unit designed from the ground up for simplicity without sacrificing capability.

Platform First Hybrid Axial Advanced Life Support Pump
Form Factor Laptop-sized · Portable
Status Bench & In Vivo Testing Complete
Pathway FDA Regulatory Submission
Step 02 / 03

The Circuit
Activates.

A venous cannula draws deoxygenated blood from the patient. The Eleusô pump — using its mixed flow axial design — moves blood through the circuit with precision. The oxygenator membrane performs gas exchange: removing CO₂, delivering O₂.

Flow Rate 5+L / min
Venous Circuit Deoxygenated blood drawn in
Oxygenator Membrane gas exchange · CO₂ out, O₂ in
Setup Time Dramatically simplified
Step 03 / 03

Life
Sustained.

Oxygenated blood returns through the arterial circuit — restoring respiratory function while the lungs recover. Eleusô's intelligent platform monitors and adapts in real time. The result: Advanced Life Support available not just in large academic centers, but wherever patients need it.

Circuit V-V & V-A
CANULA Flexible single or dual lumen
OXYGENATOR your choice
Target Settings OR, ED, ICU, EMS
01 / The Device

A 2.5 lb pump.
For a 150,000-patient gap.

The CDX system consolidates pump and motor into a single disposable, replacing 13-26 lb bedside consoles and untethering patients from the ICU.

System weight2.5 lb total
vs. standard console13-26 lb
Blood-contact pathSingle-use
02 / The Platform

Guided activation.
No perfusionist needed.

TAP-to-prime workflow guides any trained clinician through setup. Reusable controller, disposable pump. Works with hospital-sourced oxygenators.

Setup workflowTAP-to-prime
OxygenatorHospital-sourced
Target flow5+ L/min
03 / The Circuit

One closed loop.
Everywhere you need it.

Venous blood drains, passes through the oxygenator, and returns oxygenated at 5+ L/min. Light enough to walk to the ambulance.

Hemolysis profileLower than predicate
Animal studiesUp to 2 weeks
Patents issued5 across 3 families
The Platform

The first platform designed to
break the bottleneck.

Over 370,000 people in the US could benefit from Advanced Life Support each year. Access remains limited because today's systems require too much — too much space, too many specialists, too many resources. Eleusô is changing that.

01
Compact & Portable Design
Laptop-sized form factor. Designed for deployment beyond the ICU — in peripheral care units, transport environments, and emergency settings where current Advanced Life Support cannot go.
02
Practically Automated
Setup, priming, and pump engagement are streamlined through smart automation. Reduced clinician workload means faster deployment and access for more patients across more care settings.
03
Intelligent Monitoring
Real-time adaptive monitoring built into the platform. Smart pumps that can be fine-tuned to patient volume and configuration — because one size does not fit all in critical care.
04
Platform for Broader Care
Built for both acute and chronic respiratory care. Targets ARDS, COPD, ILD, and transplant recovery — conditions currently underserved by traditional Advanced Life Support infrastructure and protocols.
Competitive Advantage

What sets Eleusô apart.

Legacy systems are large and resource heavy to operate. Eleusô's unique combination of portability, automation, and intelligent platform architecture opens an entirely new way to manage a patient, especially when immediate access followed by transport is the priority to save lives. Eleusô is the first to combine all three: compact, smart, and scalable to the fast moving acute advanced care environment.

Capability Eleusô Competitors
Compact / Portable ✓ ✗
Practically Automated Setup ✓ ✗
Non-ICU Deployment Ready ✓ ✗
Intelligent Real-Time Monitoring ✓ ✗
Acute to Chronic Scalability ✓ Partial
Simplified Training Requirements ✓ ✗
On the Global Stage

Conference Presence

LSI Europe London
LSI Europe — London
Dr. Chopra joins as featured presenter · 10,000+ global executives
LSI USA San Diego
LSI USA — San Diego
1,500+ executives · Premier medtech dealmaking forum
Recognition

On Stage. On Record.

🏆 THT24 Shark Tank Competition Winner
Leadership

Built by the best in the field.

Management
Dr. Gopal K. Chopra
Dr. Gopal K. Chopra
MD Dip. Anat. FRACS MBA · Co-CEO
Neurosurgeon, Stanford & Duke faculty, former Lazard banker. 20+ years in medical devices, diagnostics, and clinical AI. Three med/health-tech companies built to major exits.
LinkedIn
Rick Smith
Rick Smith
Co-CEO
Former CEO of BioScrip (OptionCare), President of OptionCare, and CEO of Coram Healthcare (CVS). Built clinical programs managing 5,000+ heart failure patients monthly.
LinkedIn
Dr. Priya Gaiha
Dr. Priya Gaiha
MD MBA · CMO & Growth Officer
Physician-executive at the intersection of clinical strategy, medical affairs, and commercial growth in medtech. Leadership roles in structural heart, cardiovascular and neurovascular public and private companies.
LinkedIn
Trevor Snyder PhD
Trevor Snyder, Ph.D.
CTO
20+ years designing life-supporting medical devices — heart pumps, artificial lungs, and Advanced Life Support. PhD Bioengineering, Univ. of Pittsburgh. PI on 4 clinical trials, inventor on 5 patents.
LinkedIn
Board of Directors
Dr. Gopal K. Chopra
Dr. Gopal K. Chopra
Director
Co-founder and managing partner of TCG. 20+ years across medical device, diagnostics, IT, and pharma. Neurosurgeon, Stanford & Duke faculty.
LinkedIn
Rick Smith
Rick Smith
Director
Co-CEO and CFO of CDX. Former CEO of BioScrip, a billion-dollar specialty pharmacy serving 40,000 patients monthly. Former President of OptionCare.
LinkedIn
Aaron Chan
Aaron Chan
Director
Founder of Recurve Capital. 20+ years managing billions in client assets across Technology, Media, Telecom, and Consumer. CIO of Kiani Preserve. BS Stanford.
LinkedIn
Peter Aherne
Peter Aherne
Director
Recognized leader in global debt capital markets. Delivered innovative financial strategies and complex transaction structuring. Multi-billion-dollar deal track record.
LinkedIn
Ken Buck
Ken Buck
Director
Former U.S. Congressman and federal prosecutor. Deep expertise in policy, regulatory affairs, and strategic counsel for complex emerging-technology companies.
LinkedIn
Board Advisors
Joe Kiani
Joe Kiani
Board Advisor
Founder of Masimo, one of the world's most admired medical technology companies. Inventor of noninvasive patient monitoring. Founder, Patient Safety Movement Foundation (2012).
LinkedIn
Lt. General Eric Wesley
Eric Wesley
Board Advisor
Retired U.S. Army Lt. General with distinguished command at the highest levels. Brings executive leadership, strategic operations, and national-scale organizational experience to Eleusô.
LinkedIn
Press & News

In the news.

View All Press →
Get in Touch

Ready to learn
more about Eleusô?

Whether you're an investor, healthcare provider, or strategic partner — we'd love to connect. We respond to every message personally.

Use the form for direct inquiries Boston, MA

Verification required. Sent securely. We respond personally.